BIO-TECHNE Corp
TECH· Nasdaq
Filed Feb 7, 2012 · 10-Q · 38 days after period end · 0001193125-12-043543
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Revenue | $74.66M | $67.71M | $65.52M |
| Net Income | $25.81M | $26.53M | $24.72M |
| EPS Diluted | $0.70 | $0.71 | $0.66 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
ended Dec 31, 2011 · filed Feb 7, 2012 · 38 d after period end